The evaluation of effectiveness of topical chamomile flower extract in sesame oil on clinical symptoms in patients with knee osteoarthritis
- Conditions
- Knee osteoarthritis.Gonarthrosis
- Registration Number
- IRCT2015013120885N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 99
the age between 38-65 years; patient's written informed consent for inclusion; recognition of osteoarthritis by the physiatrist according to American college of rheumatology classification criteria; recognition of grade I to III by the physiatrist osteoarthritis according to Kellegren-Lawrence system of classification.
those who need more than 2 grams of acetaminophen per day; those who need to use other oral or intravenous analgesic; unwillingness to continue to participate in the study; sensitivity to study drugs; patients with other bone joint disorders like rheumatoid arthritis, gout, pseudo gout, infected arthritis, metabolic arthritis, traumatic arthritis, joint replacement, fibromyalgia, non-motor dysfunction related to hip or knee (radiculopathy and neuropathy); concomitant use of glucosamine and chondroitin sulfate; knee corticosteroid injection in the past 3 months; other articular corticosteroid injection in the past 1 month; taking muscle relaxant drugs; pregnancy; oral and local use of corticosteroid in 14 past days; muscle corticosteroid injection in the past 1 month; alcohol addicted; drug abuse; skin diseases in knee; patients with active renal, liver and peptic ulcer diseases; disability to cooperate in filling the forms (cognitive or language disorder).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;Joint stiffness. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;The need for acetaminophen 500 milligrams tablets. Timepoint: 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: Asking from patients.
- Secondary Outcome Measures
Name Time Method